Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2022 Feb;18(2):95-96.
doi: 10.1200/OP.21.00540. Epub 2021 Sep 21.

We Should Treat Financial Toxicity With Curative, Rather Than Palliative, Intent

Aaron P Mitchell  1
Affiliations
Editorial

We Should Treat Financial Toxicity With Curative, Rather Than Palliative, Intent

Aaron P Mitchell. JCO Oncol Pract. 2022 Feb.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Aaron P. MitchellOpen Payments Link: https://openpaymentsdata.cms.gov/physician/574689No other potential conflicts of interest were reported.

Comment on

References

    1. Jeong AY, Schwartz EB, Roman AR, et al. : Characterizing out-of-pocket payments and financial assistance for patients prescribed abiraterone and enzalutamide at an academic cancer center specialty pharmacy. JCO Oncol Pract 18:e284-e292, 2022 - PMC - PubMed
    1. Olszewski AJ, Zullo AR, Nering CR, et al. : Use of charity financial assistance for novel oral anticancer agents. JCO Oncol Pract 14:e221-e228, 2018 - PMC - PubMed
    1. Mitchell A, Muluneh B, Patel R, et al. : Pharmaceutical assistance programs for cancer patients in the era of orally administered chemotherapeutics. J Oncol Pharm Pract 24:424-432, 2018 - PubMed
    1. Doshi JA, Li P, Huo H, et al. : High cost sharing and specialty drug initiation under Medicare Part D: A case study in patients with newly diagnosed chronic myeloid leukemia. Am J Manag Care 22:s78-s86, 2016. (4 suppl) - PubMed
    1. Winn AN, Keating NL, Dusetzina SB: Factors associated with tyrosine kinase inhibitor initiation and adherence among Medicare beneficiaries with chronic myeloid leukemia. J Clin Oncol 34:4323-4328, 2016 - PMC - PubMed